Interestingly, GLP-1R negative malignant insulinomas and a majority of somatostatin negative NETs express enhanced GIPR levels16, rendering this receptor an interesting target for NET and insulinoma imaging. This evidence concerns the gene GLP1R and pancreatic insulinoma.